TY - JOUR
T1 - Overcoming psychological insulin resistance
T2 - A practical guide for healthcare professionals
AU - Snoek, Frank J.
AU - Fisher, Lawrence
AU - Polonsky, William H.
AU - Stuckey, Heather
AU - Hessler, Danielle
AU - Tang, Tricia
AU - Hermanns, Norbert
AU - Mundet, Xavier
AU - Silva, Maria
AU - Sturt, Jackie
AU - Okazaki, Kentaro
AU - Hadjiyianni, Irene
AU - Desai, Urvi
AU - Perez-Nieves, Magaly
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Despite the demonstrated benefits of using insulin, nearly a third of the patients with type 2 diabetes (T2D) are initially reluctant to initiate insulin therapy when it is first recommended by their healthcare provider (HCP). Several studies have documented the reasons for this phenomenon known as psychological insulin resistance (PIR) and also identified actionable strategies for HCPs to assist people with T2D to overcome their PIR. However, most strategies are based on the experiences of HCPs, rather than of patients. Based on findings from a study exploring real-world patient experience around HCP actions for mitigating PIR, we suggest that HCPs use collaborative strategies throughout the course of T2D treatment to 1) explore reasons for PIR, 2) help patients overcome PIR, and 3) follow-up regarding experience with insulin.
AB - Despite the demonstrated benefits of using insulin, nearly a third of the patients with type 2 diabetes (T2D) are initially reluctant to initiate insulin therapy when it is first recommended by their healthcare provider (HCP). Several studies have documented the reasons for this phenomenon known as psychological insulin resistance (PIR) and also identified actionable strategies for HCPs to assist people with T2D to overcome their PIR. However, most strategies are based on the experiences of HCPs, rather than of patients. Based on findings from a study exploring real-world patient experience around HCP actions for mitigating PIR, we suggest that HCPs use collaborative strategies throughout the course of T2D treatment to 1) explore reasons for PIR, 2) help patients overcome PIR, and 3) follow-up regarding experience with insulin.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103411352&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33785288
U2 - 10.1016/j.pcd.2021.03.001
DO - 10.1016/j.pcd.2021.03.001
M3 - Comment/Letter to the editor
C2 - 33785288
SN - 1751-9918
VL - 15
SP - 619
EP - 621
JO - Primary care diabetes
JF - Primary care diabetes
IS - 3
ER -